Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Oct, 2019 | Pages:
125 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)
The global enzyme replacement therapy market size is expected to reach USD 12.13 billion by 2026, expanding at a CAGR of 7.7% during the forecast period, according to a new report by Grand View Research, Inc. As per the Genetic and Rare Diseases Information Center or GARD, a rare disease is defined as a condition that affects lesser than 200,000 individuals. These disorders are also called orphan diseases due to the lack of support exhibited by pharmaceutical companies previously. Since the passing of the Orphan Drug Act of 1983 in the U.S., several large pharmaceutical and biopharmaceutical companies have invested heavily in the development of orphan drugs. Thus, rising awareness, increasing R&D investment, growth in the number of lysosomal storage and genetic disorders, and easy drug approval process are factors propelling the market growth during the forecast period. According to data from the National Institutes of Health, it is estimated that over 25 million Americans suffer from rare diseases. These facts are indicative of the fact that although the number of these ailments is low, individuals suffering from these are large. Some of the most common lysosomal storage disorders that make use of enzyme replacement therapy are Gaucher, Fabry, Pompe, MPS, SCID, and Shwachman-Diamond Syndrome among others. In the recent past, these disorders have been gaining significant attention, impacting growth positively. Various grants and acts are in place to accommodate drug makers to invest in the development of orphan drugs. Orphan Drug Designation Program, Rare Pediatric Disease Priority Review Voucher Program, Humanitarian Use Device (HUD) Program, and Orphan Products Clinical Trials Grants Program are programs that aid in the development of orphan drugs. The rising use of enzyme replacement therapy in home care and infusion centers are gaining traction in the market. Specialized infusion centers such as these are anticipated to witness the highest CAGR during the forecast period. Hospitals held the largest segmental share owing to easy accessibility and ability to treat a wide range of ailments. Further key findings from the report suggest: • The high prevalence of Gaucher disease is attributable to the Imiglucerase segment gaining the highest CAGR during the forecast period. • MPS I is anticipated to gain the highest share in the near future owing to rising prevalence and increasing cognizance about lysosomal storage diseases. • The North America region is leading the regional sector and expected to dominate the market during the forecast period owing to the existence of a large number of major players and a high incidence of lysosomal storage diseases. • The Asia Pacific region is expected to grow at the highest growth rate during the forecast period. High population bases teamed with the rising incidence of genetically acquired diseases such as Gaucher and Fabry are major factors attributing to regional growth. • Some of the major players include in the enzyme replacement therapy market are Shire plc; Sanofi; Biomarin Therapeutics; AbbVie; Alexion; Allergan; Horizon Therapeutics; Actelion; Recordati Rare Diseases; and Protalix Biotherapeutics among others.
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.4 Purchased database
1.5 GVR's internal database
1.6 Secondary sources & third party perspectives
1.7 Primary research
1.8 Information analysis
1.9 Data analysis models
1.10 Market formulation & data visualization
1.11 Data validation & publishing
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Enzyme Replacement Therapy Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Ancillary Market Outlook
3.3 Regulatory Framework
3.3.1 Reimbursement framework
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Rising prevalence of rare diseases
3.4.1.2 Rising demand for enzyme replacement therapy due to fewer side effects
3.4.1.3 Easy approval process for enzyme replacement therapy products
3.4.2 Market Restraint Analysis
3.4.2.1 Alternative treatment options
3.5 Enzyme Replacement Therapy Market Analysis Tools
3.5.1 Industry analysis - Porter's
3.5.1.1 Supplier Power
3.5.1.2 Buyer Power
3.5.1.3 Substitution Threat
3.5.1.4 Threat from new entrants
3.5.1.5 Competitive Rivalry
3.5.2 PESTEL Analysis
3.5.2.1 Political Landscape
3.5.2.2 Environmental Landscape
3.5.2.3 Social landscape
3.5.2.4 Services landscape
3.5.2.5 Legal Landscape
3.5.3 Major deals and strategic alliances analysis
3.5.3.1 Joint ventures
3.5.3.2 Mergers and acquisitions
3.5.3.3 Licensing and partnership
3.5.3.4 Services collaborations
3.5.3.5 Strategic Divestments
Chapter 4 Enzyme Replacement Therapy Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company Categorization
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.2 Key company market share analysis, 2018
4.4 Public Companies
4.4.1 Company market position analysis
4.4.2 Company market share, by region
4.4.3 Competitive dashboard analysis
4.5 Private Companies
4.5.1 List of key emerging companies
4.5.2 Regional network map
4.5.3 Company market position analysis
4.5.4 Supplier ranking
Chapter 5 Enzyme Replacement Therapy Market: Enzyme Estimates and Trend Analysis
5.1 Definition & Scope
5.2 Enzyme Market Share Analysis, 2018 & 2026
5.3 Segment Dashboard
5.4 Global Enzyme Replacement Therapy Market, by Enzyme, 2015 to 2026
5.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026
5.6 Imiglucerase
5.6.1 Imiglucerase Market, 2015 to 2026 (USD Million)
5.7 Agalsidase Beta
5.7.1 Agalsidase Beta Market, 2015 to 2026 (USD Million)
5.8 Taliglucerase
5.8.1 Taliglucerase Market, 2015 to 2026 (USD Million)
5.9 Velaglucerase Alfa
5.9.1 Velaglucerase Alfa Market, 2015 to 2026 (USD Million)
5.10 Laronidase
5.10.1 Laronidase Market, 2015 to 2026 (USD Million)
5.11 Galsulfase
5.11.1 Galsulfase Market, 2015 to 2026 (USD Million)
5.12 Idursulfase
5.12.1 Idursulfase Market, 2015 to 2026 (USD Million)
5.13 Pancreatic Enzymes
5.13.1 Pancreatic Enzymes Market, 2015 to 2026 (USD Million)
5.14 Pegademase
5.14.1 Pegademase Market, 2015 to 2026 (USD Million)
5.15 Other Enzymes
5.15.1 Other Enzymes Market, 2015 to 2026 (USD Million)
Chapter 6 Enzyme Replacement Therapy Market: Therapeutic Condition Estimates and Trend Analysis
6.1 Definition & Scope
6.2 Therapeutic Condition Market Share Analysis, 2018 & 2026
6.3 Segment Dashboard
6.4 Global Enzyme Replacement Therapy Market, by Therapeutic Condition, 2015 to 2026
6.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026
6.6 Gaucher Disease
6.6.1 Gaucher Disease Market, 2015 to 2026 (USD Million)
6.7 Fabry Disease
6.7.1 Fabry Disease Market, 2015 to 2026 (USD Million)
6.8 Pompe Disease
6.8.1 Pompe Disease Market, 2015 to 2026 (USD Million)
6.9 SCID
6.9.1 SCID Market, 2015 to 2026 (USD Million)
6.10 MPS
6.10.1 MPS Market, 2015 to 2026 (USD Million)
6.10.1.1 MPS I Market, 2015 to 2026 (USD Million)
6.10.1.2 MPS II Market, 2015 to 2026 (USD Million)
6.10.1.3 MPS III Market, 2015 to 2026 (USD Million)
6.10.1.4 Other MPS Forms Market, 2015 to 2026 (USD Million)
6.11 Other diseases
6.11.1 Other diseases Market, 2015 to 2026 (USD Million)
Chapter 7 Enzyme Replacement Therapy Market: Route of Administration Estimates and Trend Analysis
7.1 Definition & Scope
7.2 Route of Administration Market Share Analysis, 2018 & 2026
7.3 Segment Dashboard
7.4 Global Enzyme Replacement Therapy Market, by Route of Administration, 2015 to 2026
7.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026
7.6 Oral
7.6.1 Oral Market, 2015 to 2026 (USD Million)
7.7 Parenteral
7.7.1 Parenteral Market, 2015 to 2026 (USD Million)
Chapter 8 Enzyme Replacement Therapy Market: Regional Estimates & Trend Analysis
8.1 Regional Market Snapshot
8.2 Market Share Analysis by Country, 2018
8.2.1 North America
8.2.1.1 U.S.
8.2.1.2 Canada
8.2.2 Europe
8.2.2.1 UK
8.2.2.2 Germany
8.2.2.3 Spain
8.2.2.4 France
8.2.2.5 Italy
8.2.2.6 Russia
8.2.3 Latin America
8.2.3.1 Brazil
8.2.3.2 Mexico
8.2.3.3 Argentina
8.2.4 Asia Pacific
8.2.4.1 Japan
8.2.4.2 China
8.2.4.3 India
8.2.4.4 South Korea
8.2.4.5 Australia
8.2.5 Middle East & Africa
8.2.5.1 South Africa
8.2.5.2 Saudi Arabia
8.2.5.3 UAE
8.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
8.3.1 North America
8.3.2 Europe
8.3.3 Latin America
8.3.4 Asia Pacific
8.3.5 Middle East & Africa
8.4 Market Size & Forecasts, and Trend Analysis, 2018 to 2026
8.4.1 North America
8.4.1.1 North America Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
8.4.1.2 U.S.
8.4.1.2.1 Market Size & Forecasts And Trend Analysis, By Enzyme, 2015 To 2026 (USD Million)
8.4.1.2.2 Market Size & Forecasts And Trend Analysis, By Therapeutic Condition, 2015 To 2026 (USD Million)
8.4.1.2.3 Market Size & Forecasts And Trend Analysis, By Route Of Administration, 2015 To 2026 (USD Million)
8.4.1.2.4 Market Size & Forecasts And Trend Analysis, By End Use, 2015 To 2026 (USD Million)
8.4.1.3 Canada
8.4.1.3.1 Market Size & Forecasts And Trend Analysis, By Enzyme, 2015 To 2026 (USD Million)
8.4.1.3.2 Market Size & Forecasts And Trend Analysis, By Therapeutic Condition, 2015 To 2026 (USD Million)
8.4.1.3.3 Market Size & Forecasts And Trend Analysis, By Route Of Administration, 2015 To 2026 (USD Million)
8.4.1.3.4 Market Size & Forecasts And Trend Analysis, By End Use, 2015 To 2026 (USD Million)
8.4.2 Europe
8.4.2.1 Europe Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
8.4.2.2 UK
8.4.2.2.1 Market Size & Forecasts And Trend Analysis, By Enzyme, 2015 To 2026 (USD Million)
8.4.2.2.2 Market Size & Forecasts And Trend Analysis, By Therapeutic Condition, 2015 To 2026 (USD Million)
8.4.2.2.3 Market Size & Forecasts And Trend Analysis, By Route Of Administration, 2015 To 2026 (USD Million)
8.4.2.2.4 Market Size & Forecasts And Trend Analysis, By End Use, 2015 To 2026 (USD Million)
8.4.2.3 Germany
8.4.2.3.1 Market Size & Forecasts And Trend Analysis, By Enzyme, 2015 To 2026 (USD Million)
8.4.2.3.2 Market Size & Forecasts And Trend Analysis, By Therapeutic Condition, 2015 To 2026 (USD Million)
8.4.2.3.3 Market Size & Forecasts And Trend Analysis, By Route Of Administration, 2015 To 2026 (USD Million)
8.4.2.3.4 Market Size & Forecasts And Trend Analysis, By End Use, 2015 To 2026 (USD Million)
8.4.2.4 Spain
8.4.2.4.1 Market Size & Forecasts And Trend Analysis, By Enzyme, 2015 To 2026 (USD Million)
8.4.2.4.2 Market Size & Forecasts And Trend Analysis, By Therapeutic Condition, 2015 To 2026 (USD Million)
8.4.2.4.3 Market Size & Forecasts And Trend Analysis, By Route Of Administration, 2015 To 2026 (USD Million)
8.4.2.4.4 Market Size & Forecasts And Trend Analysis, By End Use, 2015 To 2026 (USD Million)
8.4.2.5 France
8.4.2.5.1 Market Size & Forecasts And Trend Analysis, By Enzyme, 2015 To 2026 (USD Million)
8.4.2.5.2 Market Size & Forecasts And Trend Analysis, By Therapeutic Condition, 2015 To 2026 (USD Million)
8.4.2.5.3 Market Size & Forecasts And Trend Analysis, By Route Of Administration, 2015 To 2026 (USD Million)
8.4.2.5.4 Market Size & Forecasts And Trend Analysis, By End Use, 2015 To 2026 (USD Million)
8.4.2.6 Italy
8.4.2.6.1 Market Size & Forecasts And Trend Analysis, By Enzyme, 2015 To 2026 (USD Million)
8.4.2.6.2 Market Size & Forecasts And Trend Analysis, By Therapeutic Condition, 2015 To 2026 (USD Million)
8.4.2.6.3 Market Size & Forecasts And Trend Analysis, By Route Of Administration, 2015 To 2026 (USD Million)
8.4.2.6.4 Market Size & Forecasts And Trend Analysis, By End Use, 2015 To 2026 (USD Million)
8.4.2.7 Russia
8.4.2.7.1 Market Size & Forecasts And Trend Analysis, By Enzyme, 2015 To 2026 (USD Million)
8.4.2.7.2 Market Size & Forecasts And Trend Analysis, By Therapeutic Condition, 2015 To 2026 (USD Million)
8.4.2.7.3 Market Size & Forecasts And Trend Analysis, By Route Of Administration, 2015 To 2026 (USD Million)
8.4.2.7.4 Market Size & Forecasts And Trend Analysis, By End Use, 2015 To 2026 (USD Million)
8.4.3 Latin America
8.4.3.1 Latin America Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
8.4.3.2 Brazil
8.4.3.2.1 Market Size & Forecasts And Trend Analysis, By Enzyme, 2015 To 2026 (USD Million)
8.4.3.2.2 Market Size & Forecasts And Trend Analysis, By Therapeutic Condition, 2015 To 2026 (USD Million)
8.4.3.2.3 Market Size & Forecasts And Trend Analysis, By Route Of Administration, 2015 To 2026 (USD Million)
8.4.3.2.4 Market Size & Forecasts And Trend Analysis, By End Use, 2015 To 2026 (USD Million)
8.4.3.3 Mexico
8.4.3.3.1 Market Size & Forecasts And Trend Analysis, By Enzyme, 2015 To 2026 (USD Million)
8.4.3.3.2 Market Size & Forecasts And Trend Analysis, By Therapeutic Condition, 2015 To 2026 (USD Million)
8.4.3.3.3 Market Size & Forecasts And Trend Analysis, By Route Of Administration, 2015 To 2026 (USD Million)
8.4.3.3.4 Market Size & Forecasts And Trend Analysis, By End Use, 2015 To 2026 (USD Million)
8.4.3.4 Argentina
8.4.3.4.1 Market Size & Forecasts And Trend Analysis, By Enzyme, 2015 To 2026 (USD Million)
8.4.3.4.2 Market Size & Forecasts And Trend Analysis, By Therapeutic Condition, 2015 To 2026 (USD Million)
8.4.3.4.3 Market Size & Forecasts And Trend Analysis, By Route Of Administration, 2015 To 2026 (USD Million)
8.4.3.4.4 Market Size & Forecasts And Trend Analysis, By End Use, 2015 To 2026 (USD Million)
8.4.4 Asia Pacific
8.4.4.1 Asia Pacific Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
8.4.4.2 Japan
8.4.4.2.1 Market Size & Forecasts And Trend Analysis, By Enzyme, 2015 To 2026 (USD Million)
8.4.4.2.2 Market Size & Forecasts And Trend Analysis, By Therapeutic Condition, 2015 To 2026 (USD Million)
8.4.4.2.3 Market Size & Forecasts And Trend Analysis, By Route Of Administration, 2015 To 2026 (USD Million)
8.4.4.2.4 Market Size & Forecasts And Trend Analysis, By End Use, 2015 To 2026 (USD Million)
8.4.4.3 China
8.4.4.3.1 Market Size & Forecasts And Trend Analysis, By Enzyme, 2015 To 2026 (USD Million)
8.4.4.3.2 Market Size & Forecasts And Trend Analysis, By Therapeutic Condition, 2015 To 2026 (USD Million)
8.4.4.3.3 Market Size & Forecasts And Trend Analysis, By Route Of Administration, 2015 To 2026 (USD Million)
8.4.4.3.4 Market Size & Forecasts And Trend Analysis, By End Use, 2015 To 2026 (USD Million)
8.4.4.4 India
8.4.4.4.1 Market Size & Forecasts And Trend Analysis, By Enzyme, 2015 To 2026 (USD Million)
8.4.4.4.2 Market Size & Forecasts And Trend Analysis, By Therapeutic Condition, 2015 To 2026 (USD Million)
8.4.4.4.3 Market Size & Forecasts And Trend Analysis, By Route Of Administration, 2015 To 2026 (USD Million)
8.4.4.4.4 Market Size & Forecasts And Trend Analysis, By End Use, 2015 To 2026 (USD Million)
8.4.4.5 South Korea
8.4.4.5.1 Market size & forecasts and trend analysis, by enzyme, 2015 to 2026 (USD Million)
8.4.4.5.2 Market size & forecasts and trend analysis, by therapeutic condition, 2015 to 2026 (USD Million)
8.4.4.5.3 Market size & forecasts and trend analysis, by route of administration, 2015 to 2026 (USD Million)
8.4.4.5.4 Market size & forecasts and trend analysis, by end use, 2015 to 2026 (USD Million)
8.4.4.6 Australia
8.4.4.6.1 Market size & forecasts and trend analysis, by enzyme, 2015 to 2026 (USD Million)
8.4.4.6.2 Market size & forecasts and trend analysis, by therapeutic condition, 2015 to 2026 (USD Million)
8.4.4.6.3 Market size & forecasts and trend analysis, by route of administration, 2015 to 2026 (USD Million)
8.4.4.6.4 Market size & forecasts and trend analysis, by end use, 2015 to 2026 (USD Million)
8.4.5 Middle East & Africa
8.4.5.1 Middle East & Africa Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
8.4.5.2 South Africa
8.4.5.2.1 Market size & forecasts and trend analysis, by enzyme, 2015 to 2026 (USD Million)
8.4.5.2.2 Market size & forecasts and trend analysis, by therapeutic condition, 2015 to 2026 (USD Million)
8.4.5.2.3 Market size & forecasts and trend analysis, by route of administration, 2015 to 2026 (USD Million)
8.4.5.2.4 Market size & forecasts and trend analysis, by end use, 2015 to 2026 (USD Million)
8.4.5.3 Saudi Arabia
8.4.5.3.1 Market size & forecasts and trend analysis, by enzyme, 2015 to 2026 (USD Million)
8.4.5.3.2 Market size & forecasts and trend analysis, by therapeutic condition, 2015 to 2026 (USD Million)
8.4.5.3.3 Market size & forecasts and trend analysis, by route of administration, 2015 to 2026 (USD Million)
8.4.5.3.4 Market size & forecasts and trend analysis, by end use, 2015 to 2026 (USD Million)
8.4.5.4 UAE
8.4.5.4.1 Market size & forecasts and trend analysis, by enzyme, 2015 to 2026 (USD Million)
8.4.5.4.2 Market size & forecasts and trend analysis, by therapeutic condition, 2015 to 2026 (USD Million)
8.4.5.4.3 Market size & forecasts and trend analysis, by route of administration, 2015 to 2026 (USD Million)
8.4.5.4.4 Market size & forecasts and trend analysis, by end use, 2015 to 2026 (USD Million)
Chapter 9 Company Profiles
9.1 Company Profiles
9.1.1 Shire Plc
9.1.1.1 Company overview
9.1.1.2 Financial Performance
9.1.1.3 Product benchmarking
9.1.1.4 Strategic initiatives
9.1.2 Sanofi S.A.
9.1.2.1 Company overview
9.1.2.2 Financial Performance
9.1.2.3 Product benchmarking
9.1.2.4 Strategic initiatives
9.1.3 BioMarin Pharmaceutical Inc.
9.1.3.1 Company overview
9.1.3.2 Financial Performance
9.1.3.3 Product benchmarking
9.1.3.4 Strategic initiatives
9.1.4 AbbVie
9.1.4.1 Company overview
9.1.4.2 Financial Performance
9.1.4.3 Product benchmarking
9.1.4.4 Strategic initiatives
9.1.5 Alexion Pharmaceuticals Inc.
9.1.5.1 Company overview
9.1.5.2 Financial Performance
9.1.5.3 Product benchmarking
9.1.5.4 Strategic initiatives
9.1.6 Allergan plc
9.1.6.1 Company overview
9.1.6.2 Financial Performance
9.1.6.3 Product benchmarking
9.1.6.4 Strategic initiatives
9.1.7 Horizon Pharma Public Limited Company
9.1.7.1 Company overview
9.1.7.2 Financial Performance
9.1.7.3 Product benchmarking
9.1.7.4 Strategic initiatives
9.1.8 Actelion (Janssen)
9.1.8.1 Company overview
9.1.8.2 Financial Performance
9.1.8.3 Product benchmarking
9.1.8.4 Strategic initiatives
9.1.9 Recordati Rare Diseases.
9.1.9.1 Company overview
9.1.9.2 Financial Performance
9.1.9.3 Product benchmarking
9.1.9.4 Strategic initiatives
9.1.10 Protalix Biotherapeutics
9.1.10.1 Company overview
9.1.10.2 Financial Performance
9.1.10.3 Product benchmarking
9.1.10.4 Strategic initiatives
List of Tables Table 1 List of key distributors and channel partners Table 2 List of key emerging companies'/product disruptors/innovators Table 3 North America Enzyme Replacement Therapy Market, by countries, 2015 - 2026 (USD Million) Table 4 North America Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 5 North America Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 6 North America Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 7 North America Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 8 U.S. Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 9 U.S. Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 10 U.S. Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 11 U.S. Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 12 Canada Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 13 Canada Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 14 Canada Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 15 Canada Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 16 Europe Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 17 Europe Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 18 Europe Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 19 Europe Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 20 UK Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 21 UK Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 22 UK Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 23 UK Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 24 Germany Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 25 Germany Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 26 Germany Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 27 Germany Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 28 France Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 29 France Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 30 France Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 31 France Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 32 Italy Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 33 Italy Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 34 Italy Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 35 Italy Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 36 Spain Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 37 Spain Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 38 Spain Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 39 Spain Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 40 Russia Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 41 Russia Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 42 Russia Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 43 Russia Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 44 Asia Pacific Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 45 Asia Pacific Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 46 Asia Pacific Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 47 Asia Pacific Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 48 Japan Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 49 Japan Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 50 Japan Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 51 Japan Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 52 China Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 53 China Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 54 China Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 55 China Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 56 India Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 57 India Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 58 India Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 59 India Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 60 South Korea Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 61 South Korea Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 62 South Korea Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 63 South Korea Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 64 Australia Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 65 Australia Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 66 Australia Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 67 Australia Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 68 Latin America Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 69 Latin America Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 70 Latin America Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 71 Latin America Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 72 Brazil Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 73 Brazil Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 74 Brazil Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 75 Brazil Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 76 Mexico Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 77 Mexico Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 78 Mexico Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 79 Mexico Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 80 Argentina Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 81 Argentina Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 82 Argentina Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 83 Argentina Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 84 MEA Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 85 MEA Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 86 MEA Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 87 MEA Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 88 South Africa Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 89 South Africa Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 90 South Africa Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 91 South Africa Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 92 Saudi Arabia Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 93 Saudi Arabia Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 94 Saudi Arabia Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 95 Saudi Arabia Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million) Table 96 UAE Enzyme Replacement Therapy Market, by enzyme, 2015 - 2026 (USD Million) Table 97 UAE Enzyme Replacement Therapy Market, by therapeutic condition, 2015 - 2026 (USD Million) Table 98 UAE Enzyme Replacement Therapy Market, by route of administration, 2015 - 2026 (USD Million) Table 99 UAE Enzyme Replacement Therapy Market, by end use, 2015 - 2026 (USD Million)
List of Figures Fig. 1 Enzyme Replacement Therapy market segmentation Fig. 2 Market research process Fig. 3 Information procurement Fig. 4 Primary research pattern Fig. 5 Market research approaches Fig. 6 Value chain based sizing & forecasting Fig. 7 Enzyme Replacement Therapy Market snapshot (2018) Fig. 8 Enzyme Replacement Therapy Market: Segment snapshot (2018) Fig. 9 Competitive Insights (2018) Fig. 10 Parent market outlook Fig. 11 Related/ancillary market outlook Fig. 12 Penetration and growth prospect mapping Fig. 13 Industry value chain analysis Fig. 14 Consumer behavior analysis Fig. 15 Enzyme Replacement Therapy Market driver impact Fig. 16 Enzyme Replacement Therapy Market restraint impact Fig. 17 Enzyme Replacement Therapy industry challenges Fig. 18 Porter's Five Forces Analysis Fig. 19 SWOT Analysis, By Factor (Political & legal Economic and technological) Fig. 20 Strategic alliance analysis Fig. 21 Recent developments & impact analysis, by key market participants Fig. 22 Key company market share analysis, 2018 Fig. 23 Company market share/ranking, by region Fig. 24 Company market position analysis Fig. 25 Supplier ranking Fig. 26 Definition and scope, by product Fig. 27 Enzyme market share analysis, 2018 & 2026 Fig. 28 Segment dashboard Fig. 29 Global Enzyme Replacement Therapy Market, by Enzyme, 2015-2026 (USD Million) Fig. 30 Global Imiglucerase market, 2015 - 2026 (USD Million) Fig. 31 Global Taliglucerase market, 2015 - 2026 (USD Million) Fig. 32 Global Velaglucerase Alfa market, 2015 - 2026 (USD Million) Fig. 33 Global Laronidase market, 2015 - 2026 (USD Million) Fig. 34 Global Alglucosidase Alfa market, 2015 - 2026 (USD Million) Fig. 35 Global Galsulfase market, 2015 - 2026 (USD Million) Fig. 36 Global Idursulfase market, 2015 - 2026 (USD Million) Fig. 37 Global Pancreatic Enzymes market, 2015 - 2026 (USD Million) Fig. 38 Global Other Enzymes market, 2015 - 2026 (USD Million) Fig. 39 Global Enzyme Replacement Therapy Market, by therapeutic condition market, 2015 - 2026 (USD Million) Fig. 40 Global Gaucher Disease market, 2015 - 2026 (USD Million) Fig. 41 Global Fabry Disease, 2015 - 2026 (USD Million) Fig. 42 Global Pompe Disease market, 2015 - 2026 (USD Million) Fig. 43 Global SCID market, 2015 - 2026 (USD Million) Fig. 44 Global MPS market, 2015 - 2026 (USD Million) Fig. 45 Global Other disorders market, 2015 - 2026 (USD Million) Fig. 46 Global MPS I market, 2015 - 2026 (USD Million) Fig. 47 Global MPS II market, 2015 - 2026 (USD Million) Fig. 48 Global MPS III market, 2015 - 2026 (USD Million) Fig. 49 Global Other MPS forms market, 2015 - 2026 (USD Million) Fig. 50 Global Enzyme Replacement Therapy Market, by end use market, 2015 - 2026 (USD Million) Fig. 51 Global hospitals market, 2015 - 2026 (USD Million) Fig. 52 Global Infusion Centers market, 2015 - 2026 (USD Million) Fig. 53 Global other end use market, 2015 - 2026 (USD Million) Fig. 54 Enzyme Replacement market Snapshot Fig. 55 North America Enzyme Replacement Therapy Market share analysis by country, 2018 Fig. 56 Europe Enzyme Replacement Therapy Market share analysis by country, 2018 Fig. 57 Asia Pacific Enzyme Replacement Therapy Market share analysis by country, 2018 Fig. 58 Latin America Enzyme Replacement Therapy Market share analysis by country, 2018 Fig. 59 Middle East and Africa Enzyme Replacement Therapy Market share analysis by country, 2018 Fig. 60 North America SWOT analysis, by factor (political & legal, economic and technological) Fig. 61 Europe SWOT analysis, by factor (political & legal, economic and technological) Fig. 62 Asia Pacific SWOT analysis, by factor (political & legal, economic and technological) Fig. 63 Latin America SWOT analysis, by factor (political & legal, economic and technological) Fig. 64 Middle East and Africa SWOT analysis, by factor (political & legal, economic and technological)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
